PCN76 COST-EFFECTIVENESS OF WHITE BLOOD CELL GROWTH FACTOR USE AMONG ELDERLY NON-HODGKIN'S LYMPHOMA PATIENTS TREATED WITH CHEMOTHERAPY

Autor: Gruschkus, SK, Lairson, DR, Dunn, JK, Risser, JM, Du, XL

Publikováno v: In Value in Health 2010 13(3):A38-A38

PCN1 USE OF WHITE BLOOD CELL GROWTH FACTORS AND RISK OF ACUTE MYELOID LEUKEMIA OR MYELODYSPLASTIC SYNDROMES AMONG ELDERLY NON-HODGKIN'S LYMPHOMA PATIENTS

Autor: Gruschkus, SK, Lairson, D, Dunn, JK, Risser, JM, Du, XL

Publikováno v: In Value in Health 2010 13(3):A23-A23

Survival outcomes of patients with HER2/neu-positive breast cancer with germline BRCA mutations.

Autor: Akkoc Mustafayev FN; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Shukla MA; Department of Internal Medicine, Baylor College of Medicine, Houston, Texas, USA., Lanier A; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA., Milton DR; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gutierrez AM; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gruschkus SK; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lewis JE; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Murthy RK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Arun BK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Publikováno v: Cancer [Cancer] 2024 May 01; Vol. 130 (9), pp. 1600-1608. Date of Electronic Publication: 2023 Dec 15.

Immune evasion phenotype is common in Richter transformation diffuse large B-cell lymphoma variant.

Autor: El Hussein S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. elhusseinsiba@gmail.com.; Department of Pathology, The University of Rochester Medical Center, Rochester, NY, USA. elhusseinsiba@gmail.com., Medeiros LJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gruschkus SK; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wei P; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Schlette E; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fang H; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jelloul FZ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang W; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fiskus W; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yang H; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Li S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Xu J; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tang Z; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Thakral B; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jain N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wierda WG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Patel K; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bhalla KN; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Khoury JD; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jkhoury@unmc.edu.; Department of Pathology & Microbiology, The University of Nebraska Medical Center, Omaha, NE, USA. jkhoury@unmc.edu.

Publikováno v: Virchows Archiv : an international journal of pathology [Virchows Arch] 2023 Jun; Vol. 482 (6), pp. 1011-1019. Date of Electronic Publication: 2023 Mar 03.

Contrast Enhancement Patterns in Pediatric Glioblastomas.

Autor: Pokhylevych H; From the Departments of Neuroradiology., Khose S; From the Departments of Neuroradiology., Gule-Monroe MK; From the Departments of Neuroradiology., Chen MM; From the Departments of Neuroradiology., Fuller G; Pathology., Gruschkus SK; Biostatistics., Sadighi Z; Pediatric Neuro-Oncology., Zaky W; Pediatric Neuro-Oncology., Sandberg DI; Neurosurgery., McGovern SL; Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Johnson JM; From the Departments of Neuroradiology.

Publikováno v: Journal of computer assisted tomography [J Comput Assist Tomogr] 2023 Jan-Feb 01; Vol. 47 (1), pp. 115-120. Date of Electronic Publication: 2022 Sep 07.